Catalyst Wire Dossier Catalyst Wire Dossier

Sugammadex Adroiq

sugammadex sodium · Extrovis EU Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sugammadex Adroiq, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: EMA Authorised: Sugammadex Adroiq (sugammadex sodium) — Extrovis EU Ltd

See pricing